Showing results (1431-1440 of 1,640) with videos related to
Sort By:
Pageof 164
Journal of Personalized Medicine|February 25, 2023
Updated Views in Targeted Therapy in the Patient with Non-Small Cell Lung CancerMiguel A Ortega, Leonel Pekarek, Fátima Navarro, et al.Cell Death & Disease|September 12, 2019
Lung tumorspheres reveal cancer stem cell-like properties and a score with prognostic impact in resected non-small-cell lung cancerAlejandro Herreros-Pomares, Juan Diego de-Maya-Girones, Silvia Calabuig-Fariñas, et al.Genes|September 23, 2022
Fragile X Syndrome Caused by Maternal Somatic Mosaicism of FMR1 Gene: Case Report and Literature ReviewMaria Jose Gómez-Rodríguez, Montserrat Morales-Conejo, Ana Arteche-López, et al.Cancers|January 8, 2025
At-Home Care Program for Acute Myeloid Leukemia Induction Phase in Patients Treated with Venetoclax-Based Low-Intensity RegimensAlexandra Martínez-Roca, Carlos Jiménez-Vicente, Beatriz Merchán, et al.Vaccines|April 30, 2021
An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic TimesCielo García-Montero, Oscar Fraile-Martínez, Coral Bravo, et al.International Journal of Cardiology|February 23, 2016
Intramyocardial transplantation of mesenchymal stromal cells for chronic myocardial ischemia and impaired left ventricular function: Results of the MESAMI 1 pilot trialD Guijarro, M Lebrin, O Lairez, et al.British Journal of Haematology|November 28, 2023
Characteristics and long-term outcome in a large series of chronic myelomonocytic leukaemia patients including 104 formerly referred to as oligomonocyticSandra Castaño-Díez, Helena Pomares, Daniel Esteban, et al.Antimicrobial Agents and Chemotherapy|December 21, 2021
Selection of AmpC β-Lactamase Variants and Metallo-β-Lactamases Leading to Ceftolozane/Tazobactam and Ceftazidime/Avibactam Resistance during Treatment of MDR/XDR Pseudomonas aeruginosa InfectionsAlba Ruedas-López, Isaac Alonso-García, Cristina Lasarte-Monterrubio, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2016
Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 InhibitorsRenata Ferrarotto, Yoshitsugu Mitani, Lixia Diao, et al.Cancer Cell|December 25, 2018
p62/SQSTM1 Fuels Melanoma Progression by Opposing mRNA Decay of a Selective Set of Pro-metastatic FactorsPanagiotis Karras, Erica Riveiro-Falkenbach, Estela Cañón, et al.Pageof 164